PlexBio Co., Ltd.

PlexBio Co., Ltd.

TTPEX:6572
6.04
TWD
0.00
(0.00%)
714.14MMarket Cap

Total Valuation

TWD

As of June 30, 2026, PlexBio Co., Ltd. carries a market capitalization of 714.14M, placing it among publicly traded companies globally. Its enterprise value stands at 436.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap714.14M
Enterprise Value436.17M

Share Statistics

As of June 30, 2026, PlexBio Co., Ltd. has 103.65M shares outstanding.

Shares Outstanding103.65M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio2.47
P/TBV Ratio2.47

Financial Position

As of June 30, 2026, PlexBio Co., Ltd. maintains a current ratio of 4.14, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities.

Current Ratio4.14
Quick Ratio3.14
Debt / Equity1.81

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count75.00

Stock Price Statistics

TWD

As of the close on November 17, 2026, PlexBio Co., Ltd.'s stock has declined approximately 38.18% over the past 52 weeks. The 50-day moving average sits at 6.94, while the 200-day moving average is 7.80.

52-Week Price Change-38.18%
50-Day Moving Average6.94
200-Day Moving Average7.80

Balance Sheet

TWD

As of June 30, 2026, PlexBio Co., Ltd. holds 283.20M in cash and equivalents against 5.23M in total debt, resulting in a net debt position of -145.80M. Total book value stands at 289.04M, with working capital of 283.25M providing operational flexibility.

Cash & Cash Equivalents283.20M
Total Debt5.23M
Net Debt-145.80M
Equity (Book Value)289.04M
Book Value Per Share2.79
Working Capital283.25M